Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · IEX Real-Time Price · USD

1.160

+0.030 (2.65%)

At close: Jul 19, 2024, 4:00 PM

1.280

+0.120 (10.34%)

Pre-market: Jul 22, 2024, 7:38 AM EDT

Bright Minds Biosciences Income Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Selling, General & Admin	1.17	1.74	1.37	1.39	0.02	0
Research & Development	3.47	5	12.18	6.31	0.35	0.04
Other Operating Expenses	0.65	0.65	1.42	1.1	0.1	0.04
Operating Expenses	5.29	7.39	14.98	8.8	0.48	0.08
Operating Income	-5.29	-7.39	-14.98	-8.8	-0.48	-0.08
Other Expense / Income	-0.05	-0.01	-0.01	-0.15	-	-
Pretax Income	-5.24	-7.37	-14.96	-8.65	-0.48	-0.08
Net Income	-5.24	-7.37	-14.96	-8.65	-0.48	-0.08
Shares Outstanding (Basic)	4	4	2	2	1	0
Shares Outstanding (Diluted)	4	4	2	2	1	0
Shares Change	17.86%	50.57%	37.64%	148.42%	74.24%	-
EPS (Basic)	-1.36	-1.98	-6.06	-4.82	-0.65	-0.20
EPS (Diluted)	-1.36	-1.98	-6.06	-4.82	-0.65	-0.20
Free Cash Flow	-4.48	-7.02	-13.59	-7.32	-0.29	-0.04
Free Cash Flow Per Share	-1.00	-1.89	-5.50	-4.08	-0.40	-0.10
EBITDA	-5.17	-7.3	-14.96	-8.65	-0.48	-0.08
Depreciation & Amortization	0.07	0.07	0.01	0	0	0
EBIT	-5.24	-7.37	-14.96	-8.65	-0.48	-0.08

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).